Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Fowler

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
Neurology|November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older IndividualsLaura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Journal of Medicinal Chemistry|February 27, 2018
In Vitro and in Vivo Evaluation of <sup>11</sup>C-Labeled Azetidinecarboxylates for Imaging Monoacylglycerol Lipase by PET Imaging StudiesRan Cheng, Wakana Mori, Longle Ma, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2018
Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-βW M A D Binosha Fernando, Stephanie R Rainey-Smith, Samantha L Gardener, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 9, 2022
Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's diseaseXin Huang, Yihan Li, Christopher Fowler, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scansAzadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
Journal of Medicinal Chemistry|March 5, 2019
Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a "Tail Switching" Strategy on a Piperazinyl Azetidine SkeletonZhen Chen, Wakana Mori, Xiaoyun Deng, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of agingJames K Lui, Simon M Laws, Qiao-Xin Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2022
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settingsDhamidhu Eratne, Samantha M Loi, Qiao-Xin Li, et al.
Journal of Alzheimer'S Disease Reports|August 9, 2021
Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's DiseaseChristopher Fowler, Stephanie R Rainey-Smith, Sabine Bird, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Neurology|November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older IndividualsLaura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Journal of Medicinal Chemistry|February 27, 2018
In Vitro and in Vivo Evaluation of <sup>11</sup>C-Labeled Azetidinecarboxylates for Imaging Monoacylglycerol Lipase by PET Imaging StudiesRan Cheng, Wakana Mori, Longle Ma, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2018
Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-βW M A D Binosha Fernando, Stephanie R Rainey-Smith, Samantha L Gardener, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 9, 2022
Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's diseaseXin Huang, Yihan Li, Christopher Fowler, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scansAzadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
Journal of Medicinal Chemistry|March 5, 2019
Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a "Tail Switching" Strategy on a Piperazinyl Azetidine SkeletonZhen Chen, Wakana Mori, Xiaoyun Deng, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of agingJames K Lui, Simon M Laws, Qiao-Xin Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2022
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settingsDhamidhu Eratne, Samantha M Loi, Qiao-Xin Li, et al.
Journal of Alzheimer'S Disease Reports|August 9, 2021
Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's DiseaseChristopher Fowler, Stephanie R Rainey-Smith, Sabine Bird, et al.
Pageof 17